Defueling the cancer: ATP synthase as an emerging target in cancer therapy

Liberti, 2016, The Warburg effect: How does it benefit cancer cells? Trends Biochem, Sci, 41, 211 Hanahan, 2011, Hallmarks of cancer: The next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Pavlova, 2016, The emerging hallmarks of cancer metabolism, Cell Metab, 23, 27, 10.1016/j.cmet.2015.12.006 Caro, 2012, Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma, Cancer Cell, 22, 547, 10.1016/j.ccr.2012.08.014 Shi, 2019, Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma, Nature, 567, 341, 10.1038/s41586-019-0993-x Bajzikova, 2019, Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient cancer cells, Cell Metab, 29, 399, 10.1016/j.cmet.2018.10.014 Viale, 2016, Metabolic features of cancer treatment resistance, Recent Results Cancer Res., 207, 135, 10.1007/978-3-319-42118-6_6 Bosc, 2017, Resistance is futile: Targeting mitochondrial energetics and metabolism to overcome drug resistance in cancer treatment, Cell Metab, 26, 705, 10.1016/j.cmet.2017.10.013 Viale, 2014, Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function, Nature, 514, 628, 10.1038/nature13611 Esparza-Moltó, 2018, The role of mitochondrial H+-ATP synthase in cancer, Front. Oncol., 8, 53, 10.3389/fonc.2018.00053 Das, 1994, A novel ligand in lymphocyte-mediated cytotoxicity: Expression of the beta subunit of H+ transporting ATP synthase on the surface of tumor cell lines, J. Exp. Med., 180, 273, 10.1084/jem.180.1.273 Wang, 2013, The mechanism underlying the effects of the cell surface ATP synthase on the regulation of intracellular acidification during acidosis, J. Cell. Biochem, 114, 1695, 10.1002/jcb.24511 Ma, 2010, Mitochondrial F1Fo-ATP synthase translocates to cell surface in hepatocytes and has high activity in tumor-like acidic and hypoxic environment, Acta Biochim. Biophys. Sin. (Shanghai), 42, 530, 10.1093/abbs/gmq063 Wang, 2008, Effect of a novel inhibitory mAb against β-subunit of F1F0 ATPase on HCC, Cancer Biol. Ther., 7, 1829, 10.4161/cbt.7.11.6861 Chang, 2020, Multiomics reveals ectopic ATP synthase blockade induces cancer cell death via a lncRNA-mediated phospho-signaling network, Mol. Cell. Proteomics, 19, 1805, 10.1074/mcp.RA120.002219 Kim, 2020, Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis, Oncotarget, 11, 3863, 10.18632/oncotarget.27743 Okuno, 2011, Rotation and structure of FoF1-ATP synthase, J. Biochem., 149, 655, 10.1093/jb/mvr049 Pinke, 2020, Cryo-EM structure of the entire mammalian F-type ATP synthase, Nat. Struct. Mol. Biol., 27, 1077, 10.1038/s41594-020-0503-8 Srivastava, 2018, High-resolution cryo-EM analysis of the yeast ATP synthase in a lipid membrane, Science, 360, eaas9699, 10.1126/science.aas9699 Spikes, 2020, Structure of the dimeric ATP synthase from bovine mitochondria, Proc. Natl. Acad. Sci. USA, 117, 23519, 10.1073/pnas.2013998117 He, 2018, Assembly of the membrane domain of ATP synthase in human mitochondria, Proc. Natl. Acad. Sci. USA, 115, 2988, 10.1073/pnas.1722086115 Lieberthal, 1998, Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells, Am. J. Physiol., 274, F315 Niedzwiecka, 2018, Two mutations in mitochondrial ATP6 gene of ATP synthase, related to human cancer, affect ROS, calcium homeostasis and mitochondrial permeability transition in yeast. Biochim. Biophys, Acta Mol. Cell. Res, 1865, 117 Li, 2020, The mitophagy effector FUNDC1 controls mitochondrial reprogramming and cellular plasticity in cancer cells, Sci. Signal, 13, eaaz8240, 10.1126/scisignal.aaz8240 Gale, 2020, Acquired resistance to HER2-targeted therapies creates vulnerability to ATP synthase inhibition, Cancer Res., 80, 524, 10.1158/0008-5472.CAN-18-3985 Xu, 2016, ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation, J. Neurooncol., 126, 405, 10.1007/s11060-015-1984-x Muys, 2019, miR-450a acts as a tumor suppressor in ovarian cancer by regulating energy metabolism, Cancer Res., 79, 3294, 10.1158/0008-5472.CAN-19-0490 Speransky, 2019, A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer, Breast Cancer Res. Treat., 176, 271, 10.1007/s10549-019-05174-3 Bikas, 2019, Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells, Int. J. Oncol., 55, 7 Yuan, 2018, A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co-expression analysis, Oncol. Rep., 39, 525 Chang, 2017, Estrogen enhances the expression of the multidrug transporter gene ABCG2—Increasing drug resistance of breast cancer cells through estrogen receptors, Int. J. Mol. Sci., 18, E163, 10.3390/ijms18010163 Feichtinger, 2018, Reduced levels of ATP synthase subunit ATP5F1A correlate with earlier-onset prostate cancer, Oxid. Med. Cell. Longev., 2018, 1347174, 10.1155/2018/1347174 Seth, 2009, The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability, J. Clin. Pathol., 62, 598, 10.1136/jcp.2009.064436 Liu, 2019, Network pharmacology-based analysis of mechanisms of the anti-hepatocellular carcinoma effect by dihydroartemisinin, Discov. Med., 28, 139 Lu, 2014, Comparative proteomic analysis of anti-cancer mechanism by periplocin treatment in lung cancer cells, Cell. Physiol. Biochem., 33, 859, 10.1159/000358658 Ratajczak, 2019, Monitoring of dynamic ATP level changes by oligomycin-modulated ATP synthase inhibition in SW480 cancer cells using fluorescent “On-Off” switching DNA aptamer, Anal. Bioanal. Chem., 411, 6899, 10.1007/s00216-019-02061-0 Di Virgilio, 2018, Extracellular ATP and P2 purinergic signalling in the tumour microenvironment, Nat. Rev. Cancer, 18, 601, 10.1038/s41568-018-0037-0 Pellegatti, 2008, Increased level of extracellular ATP at tumor sites: In vivo imaging with plasma membrane luciferase, PLoS ONE, 3, e2599, 10.1371/journal.pone.0002599 Astakhova, 2019, Inhibitors of oxidative phosphorylation modulate astrocyte inflammatory responses through AMPK-dependent Ptgs2 mRNA stabilization, Cells, 8, E1185, 10.3390/cells8101185 Park, 2019, Zr-89 immuno-PET targeting ectopic ATP synthase enables in-vivo imaging of tumor angiogenesis, Int. J. Mol. Sci., 20, E3928, 10.3390/ijms20163928 Chang, 2012, Ectopic ATP synthase blockade suppresses lung adenocarcinoma growth by activating the unfolded protein response, Cancer Res., 72, 4696, 10.1158/0008-5472.CAN-12-0567 Wang, 2019, Ectopic ATP synthase β subunit proteins on human leukemia cell surface interact with platelets by binding glycoprotein IIb, Haematologica, 104, e364, 10.3324/haematol.2019.216390 Bianchi, 2018, Curcumin induces a fatal energetic impairment in tumor cells in vitro and in vivo by inhibiting ATP-synthase activity, Carcinogenesis, 39, 1141, 10.1093/carcin/bgy076 Salomon, 2001, Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase, Chem. Biol., 8, 71, 10.1016/S1074-5521(00)00057-0 Mowery, 2008, Targeting cell surface F1F0 ATP synthase in cancer therapy, Cancer Biol. Ther., 7, 1836, 10.4161/cbt.7.11.7155 Hong, 2008, ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas, Microbiol. Mol. Biol. Rev, 72, 590, 10.1128/MMBR.00016-08 Patel, 2020, Natural products and other inhibitors of F1FO ATP synthase, Eur. J. Med. Chem, 207, 112779, 10.1016/j.ejmech.2020.112779 Narang, 2019, Recent advancements in mechanistic studies and structure activity relationship of FoF1 ATP synthase inhibitor as antimicrobial agent, Eur. J. Med. Chem, 182, 111644, 10.1016/j.ejmech.2019.111644 Arakaki, 2007, Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs, FEBS Lett., 581, 3405, 10.1016/j.febslet.2007.06.041 Huang, 2008, Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B, J. Proteome Res., 7, 1433, 10.1021/pr700742h Devenish, 2000, The oligomycin axis of mitochondrial ATP synthase: OSCP and the proton channel, J. Bioenerg. Biomembr., 32, 507, 10.1023/A:1005621125812 Tan, 2019, New high-throughput screening identifies compounds that reduce viability specifically in liver cancer cells that express high levels of SALL4 by inhibiting oxidative phosphorylation, Gastroenterology, 157, 1615, 10.1053/j.gastro.2019.08.022 Lin, 2018, Role of mitochondrial function in the invasiveness of human colon cancer cells, Oncol. Rep., 39, 316 Wender, 2007, Isolation, structure determination, and anti-cancer activity of apoptolidin D, Org. Lett., 9, 691, 10.1021/ol0630245 Wender, 2005, Apoptolidins B and C: Isolation, structure determination, and biological activity, Org. Lett., 7, 3025, 10.1021/ol051074o Wang, 2014, Novel insights of dietary polyphenols and obesity, J. Nutr. Biochem., 25, 1, 10.1016/j.jnutbio.2013.09.001 Rauf, 2018, Resveratrol as an anti-cancer agent: A review, Crit. Rev. Food Sci. Nutr., 58, 1428, 10.1080/10408398.2016.1263597 Fliedner, 2015, Potential therapeutic target for malignant paragangliomas: ATP synthase on the surface of paraganglioma cells, Am. J. Cancer Res., 5, 1558 Valenti, 2013, Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells, Biochim. Biophys. Acta, 1832, 2085, 10.1016/j.bbadis.2013.07.014 Khiewkamrop, 2018, Epistructured catechins, EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cells, Cancer Cell Int., 18, 46, 10.1186/s12935-018-0539-6 Liu, 2013, Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors, J. Surg. Res, 183, 397, 10.1016/j.jss.2012.11.041 Nelson, 2017, The essential medicinal chemistry of curcumin, J. Med. Chem., 60, 1620, 10.1021/acs.jmedchem.6b00975 Rawat, 2018, An overview of natural plant products in the treatment of hepatocellular carcinoma, Anticancer. Agents Med. Chem., 18, 1838, 10.2174/1871520618666180604085612 Dang, 2015, Curcumin improves the paclitaxel-induced apoptosis of HPV-positive human cervical cancer cells via the NF-κB-p53-caspase-3 pathway, Exp. Ther. Med., 9, 1470, 10.3892/etm.2015.2240 Faião-Flores, 2012, DM-1, sodium 4-[5-(4-hydroxy-3-methoxyphenyl)-3-oxo-penta-1,4-dienyl]-2-methoxy-phenolate: A curcumin analog with a synergic effect in combination with paclitaxel in breast cancer treatment, Tumour Biol., 33, 775, 10.1007/s13277-011-0293-z Chen, 2015, Curcumin-based anti-prostate cancer agents, Anticancer. Agents Med. Chem., 15, 138, 10.2174/1871520615666150116102442 Wan Mohd Tajuddin, 2019, Mechanistic understanding of curcumin’s therapeutic effects in lung cancer, Nutrients, 11, E2989, 10.3390/nu11122989 Deguchi, 2015, Curcumin targets in inflammation and cancer, Endocr. Metab. Immune Disord. Drug Targets, 15, 88, 10.2174/1871530315666150316120458 Alvarez-Delgado, 2010, Different expression of alpha and beta mitochondrial estrogen receptors in the aging rat brain: Interaction with respiratory complex V, Exp. Gerontol, 45, 580, 10.1016/j.exger.2010.01.015 Massart, 2002, Dose-dependent inhibition of mitochondrial ATP synthase by 17 beta-estradiol, Gynecol. Endocrinol., 16, 373, 10.1080/gye.16.5.373.377 Zheng, 1999, Purification and identification of an estrogen binding protein from rat brain: Oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase, J. Steroid Biochem. Mol. Biol., 68, 65, 10.1016/S0960-0760(98)00161-7 Zheng, 1999, Rapid inhibition of rat brain mitochondrial proton F0F1-ATPase activity by estrogens: comparison with Na+, K+-ATPase of porcine cortex, Eur. J. Pharmacol., 368, 95, 10.1016/S0014-2999(99)00012-6 Pitt, 2017, A concise history of mycotoxin research, J. Agric. Food Chem., 65, 7021, 10.1021/acs.jafc.6b04494 Kumar, 2018, Estradiol: A steroid with multiple facets, Horm. Metab. Res., 50, 359, 10.1055/s-0044-100920 Chinnam, 2010, Dietary bioflavonoids inhibit Escherichia coli ATP synthase in a differential manner, Int. J. Biol. Macromol., 46, 478, 10.1016/j.ijbiomac.2010.03.009 Pons, 2014, Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio, J. Cell. Biochem, 115, 949, 10.1002/jcb.24737 Gause, 1981, Binding of citreoviridin to the β subunit of the yeast F1-ATPase, J. Biol. Chem., 256, 557, 10.1016/S0021-9258(19)70004-0 Chang, 2014, Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells, Cell Death Dis., 5, e1540, 10.1038/cddis.2014.504 Pohland, 1993, Mycotoxins in review, Food Addit. Contam., 10, 17, 10.1080/02652039309374126 Matsuno-Yagi, 1985, Studies on the mechanism of oxidative phosphorylation: Effects of specific F0 modifiers on ligand-induced conformation changes of F1, Proc. Natl. Acad. Sci. USA, 82, 7550, 10.1073/pnas.82.22.7550 Zhu, 2018, Aurovertin B sensitizes colorectal cancer cells to NK cell recognition and lysis. Biochem. Biophys, Res. Commun, 503, 3057 Long, 2016, Diasteltoxins A–C, asteltoxin-based dimers from a mutant of the sponge-associated Emericella variecolor fungus, Org. Lett., 18, 4678, 10.1021/acs.orglett.6b02313 Wu, 2015, Varioxiranols I-L, new lactones from a sponge-associated Emericella variecolor fungus, J. Asian Nat. Prod. Res., 17, 1137, 10.1080/10286020.2015.1119127 Preiss, 2015, Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline, Sci. Adv., 1, e1500106, 10.1126/sciadv.1500106 Wu, 2018, Antibiotic bedaquiline effectively targets growth, survival and tumor angiogenesis of lung cancer through suppressing energy metabolism. Biochem. Biophys, Res. Commun, 495, 267 Fiorillo, 2016, Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs), Aging (Albany NY), 8, 1593, 10.18632/aging.100983 Liu, 2016, Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress. Biochem. Biophys, Res. Commun, 480, 415 Skoda, 2019, Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies, Pharmacol. Res, 139, 298, 10.1016/j.phrs.2018.11.020 Cox, 2014, FDA approval of bedaquiline—The benefit-risk balance for drug-resistant tuberculosis, N. Engl. J. Med., 371, 689, 10.1056/NEJMp1314385 Hards, 2018, Targeting bacterial energetics to produce new antimicrobials, Drug Resist. Updat, 36, 1, 10.1016/j.drup.2017.11.001 Elbehairi, 2020, Role of Pd(II)-chitooligosaccharides-Gboxin analog in oxidative phosphorylation inhibition and energy depletion: Targeting mitochondrial dynamics, Chem. Biol. Drug Des., 96, 1148, 10.1111/cbdd.13703 Gajate, 2014, Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine, Anticancer. Agents Med. Chem., 14, 509, 10.2174/1871520614666140309222259 Villa-Pulgarín, 2017, Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine, PLoS Negl. Trop. Dis., 11, e0005805, 10.1371/journal.pntd.0005805 van Blitterswijk, 2013, Anticancer mechanisms and clinical application of alkylphospholipids, Biochim. Biophys. Acta, 1831, 663, 10.1016/j.bbalip.2012.10.008 Mollinedo, 2011, Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria, Cell Death Dis., 2, e158, 10.1038/cddis.2011.41 Dorlo, 2012, Miltefosine: A review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis, J. Antimicrob. Chemother., 67, 2576, 10.1093/jac/dks275 Mollinedo, 2014, Editorial: Antitumor alkylphospholipid analogs: A promising and growing family of synthetic cell membrane-targeting molecules for cancer treatment), Anticancer. Agents Med. Chem., 14, 495, 10.2174/1871520614999140313160011 Zaremberg, 2020, Lipids and membrane microdomains: The glycerolipid and alkylphosphocholine class of cancer chemotherapeutic drugs, Handb. Exp. Pharmacol., 259, 261, 10.1007/164_2019_222 Esparza-Moltó, 2017, Regulation of the H+-ATP synthase by IF1: A role in mitohormesis, Cell. Mol. Life Sci., 74, 2151, 10.1007/s00018-017-2462-8 González-Llorente, 2019, Overexpression of mitochondrial IF1 prevents metastatic disease of colorectal cancer by enhancing anoikis and tumor infiltration of NK cells, Cancers (Basel), 12, E22, 10.3390/cancers12010022 Sgarbi, 2018, Hypoxia and IF1 expression promote ROS decrease in cancer cells, Cells, 7, E64, 10.3390/cells7070064 Jung, 2007, Direct targeting of tumor cell F1F0 ATP-synthase by radioiodine angiostatin in vitro and in vivo, Cancer Biother. Radiopharm., 22, 704, 10.1089/cbr.2007.369 Chen, 2016, A humanized chimeric antibody Hai178 targeted to the β subunit of F1F0 ATP synthase, Tumour Biol., 37, 15903, 10.1007/s13277-016-5423-1 Ridley, 2009, Polyketides, 472 Penefsky, 1985, Mechanism of inhibition of mitochondrial adenosine triphosphatase by dicyclohexylcarbodiimide and oligomycin: Relationship to ATP synthesis, Proc. Natl. Acad. Sci. USA, 82, 1589, 10.1073/pnas.82.6.1589 Giorgio, 2019, OSCP subunit of mitochondrial ATP synthase: Role in regulation of enzyme function and of its transition to a pore, Br. J. Pharmacol, 176, 4247, 10.1111/bph.14513 Pacheco-Velázquez, 2018, Energy metabolism drugs block triple negative breast metastatic cancer cell phenotype, Mol. Pharm., 15, 2151, 10.1021/acs.molpharmaceut.8b00015 Sun, 2018, Increased mtDNA copy number promotes cancer progression by enhancing mitochondrial oxidative phosphorylation in microsatellite-stable colorectal cancer, Signal Transduct. Target. Ther., 3, 8, 10.1038/s41392-018-0011-z Zhang, 2020, MET inhibition elicits PGC1α-dependent metabolic reprogramming in glioblastoma, Cancer Res., 80, 30, 10.1158/0008-5472.CAN-19-1389 Huang, 2021, Targeting dormant ovarian cancer cells in vitro and in an in vivo mouse model of platinum resistance, Mol. Cancer Ther., 20, 85, 10.1158/1535-7163.MCT-20-0119 Salomon, 2000, Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F0F1-ATPase, Proc. Natl. Acad. Sci. USA, 97, 14766, 10.1073/pnas.97.26.14766 Daniel, 2006, Apoptolidin: Induction of apoptosis by a natural product, Angew. Chem. Int. Ed. Engl., 45, 872, 10.1002/anie.200502698 Wender, 2006, Correlation of F0F1-ATPase inhibition and antiproliferative activity of apoptolidin analogues, Org. Lett., 8, 589, 10.1021/ol052800q Serrill, 2015, Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A, Biochem. Pharmacol, 93, 251, 10.1016/j.bcp.2014.11.015 Yamashita, 1997, Cytovaricin B, a new inhibitor of JAK-STAT signal transduction produced by Streptomyces torulosus, J. Antibiot. (Tokyo), 50, 440, 10.7164/antibiotics.50.440 Estrela, 2017, Polyphenolic phytochemicals in cancer prevention and therapy: Bioavailability versus bioefficacy, J. Med. Chem., 60, 9413, 10.1021/acs.jmedchem.6b01026 Genestie, 2017, [Histological and molecular classification of endometrial carcinoma and therapeutical implications], Bull. Cancer, 104, 1001, 10.1016/j.bulcan.2017.08.004 Weinreb, 2008, The application of proteomics for studying the neurorescue activity of the polyphenol (−)-epigallocatechin-3-gallate, Arch. Biochem. Biophys., 476, 152, 10.1016/j.abb.2008.01.004 Kunnumakkara, 2017, Curcumin mediates anticancer effects by modulating multiple cell signaling pathways, Clin. Sci. (Lond.), 131, 1781, 10.1042/CS20160935 Moreno, 2013, Mechanism of inhibition of mitochondrial ATP synthase by 17β-estradiol, J. Bioenerg. Biomembr., 45, 261, 10.1007/s10863-012-9497-1 Schäberle, 2016, Biosynthesis of α-pyrones, Beilstein J. Org. Chem., 12, 571, 10.3762/bjoc.12.56 Hu, 2015, Temporal phosphoproteome dynamics induced by an ATP synthase inhibitor citreoviridin, Mol. Cell. Proteomics, 14, 3284, 10.1074/mcp.M115.051383 Zhao, 2016, Aurovertin-type polyketides from Calcarisporium arbuscula with potent cytotoxic activities against triple-negative breast cancer, Helvetica Chimica Acta, 99, 543, 10.1002/hlca.201600026 Wu, 2020, Aurovertin B exerts potent antitumor activity against triple-negative breast cancer in vivo and in vitro via regulating ATP synthase activity and DUSP1 expression, Pharmazie, 75, 261 Calvert, 2020, Synthetic approaches towards bedaquiline and its derivatives, Bioorg. Med. Chem. Lett, 30, 127172, 10.1016/j.bmcl.2020.127172 Nieto Ramirez, 2020, Whole genome sequencing for the analysis of drug resistant strains of Mycobacterium tuberculosis: A systematic review for bedaquiline and delamanid, Antibiotics (Basel), 9, E133, 10.3390/antibiotics9030133 Rios-Marco, 2017, Alkylphospholipids: An update on molecular mechanisms and clinical relevance, Biochim. Biophys. Acta Biomembr, 1859, 1657, 10.1016/j.bbamem.2017.02.016 Garcia-Bermudez, 2015, PKA phosphorylates the ATPase inhibitory factor 1 and inactivates its capacity to bind and inhibit the mitochondrial H+-ATP synthase, Cell. Rep, 12, 2143, 10.1016/j.celrep.2015.08.052 Cao, 2004, Angiostatin, Semin. Thromb. Hemost., 30, 83, 10.1055/s-2004-822973 Kenan, 2005, Ectopic localization of mitochondrial ATP synthase: A target for anti-angiogenesis intervention?, J. Bioenerg. Biomembr., 37, 461, 10.1007/s10863-005-9492-x Moser, 1999, Angiostatin binds ATP synthase on the surface of human endothelial cells, Proc. Natl. Acad. Sci. USA, 96, 2811, 10.1073/pnas.96.6.2811 Yuan, 2012, A monoclonal antibody against F1-F0 ATP synthase beta subunit, Hybridoma (Larchmt.), 31, 352, 10.1089/hyb.2012.0033 Wen-Li, 2012, Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines, J. Exp. Clin. Cancer Res., 31, 92, 10.1186/1756-9966-31-92 Chung, 2020, Mitochondrial oxidative phosphorylation complex regulates NLRP3 inflammasome activation and predicts patient survival in nasopharyngeal carcinoma, Mol. Cell. Proteomics, 19, 142, 10.1074/mcp.RA119.001808 Isidoro, 2004, Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer, Biochem. J., 378, 17, 10.1042/bj20031541 Dieras, 2017, Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial, Lancet Oncol, 18, 732, 10.1016/S1470-2045(17)30312-1 Verma, 2012, Trastuzumab emtansine for HER2-positive advanced breast cancer, N. Engl. J. Med., 367, 1783, 10.1056/NEJMoa1209124 Arif, 2018, Mitochondrial VDAC1 silencing leads to metabolic rewiring and the reprogramming of tumour cells into advanced differentiated states, Cancers (Basel), 10, E499, 10.3390/cancers10120499 Arif, 2019, Metabolic reprograming via silencing of mitochondrial VDAC1 expression encourages differentiation of cancer cells, Mol. Ther. Nucleic Acids, 17, 24, 10.1016/j.omtn.2019.05.003 Arif, 2019, Rewiring of cancer cell metabolism by mitochondrial VDAC1 depletion results in time-dependent tumor reprogramming: Glioblastoma as a proof of concept, Cells, 8, E1330, 10.3390/cells8111330 Amsalem, 2020, The mitochondrial protein VDAC1 at the crossroads of cancer cell metabolism: the epigenetic link, Cancers (Basel), 12, E1031, 10.3390/cancers12041031 Zerbib, 2021, VDAC1 silencing in cancer cells leads to metabolic reprogramming that modulates tumor microenvironment, Cancers (Basel), 13, 2850, 10.3390/cancers13112850 Vyas, 2016, Mitochondria and cancer, Cell, 166, 555, 10.1016/j.cell.2016.07.002 Weinberg, 2010, Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity, Proc. Natl. Acad. Sci. USA, 107, 8788, 10.1073/pnas.1003428107 Zhan, 2019, In-depth proteomics analysis to identify biomarkers of papillary thyroid cancer patients older than 45 years with different degrees of lymph node metastases, Proteomics Clin. Appl., 13, e1900030, 10.1002/prca.201900030 Henderson, 1989, Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer, J. Clin. Oncol., 7, 560, 10.1200/JCO.1989.7.5.560 Allison, 2017, Metabolic reprogramming in the tumour microenvironment: A hallmark shared by cancer cells and T lymphocytes, Immunology, 152, 175, 10.1111/imm.12777 Li, 2020, Cancer cells don’t live alone: Metabolic communication within tumor microenvironments, Dev. Cell, 54, 183, 10.1016/j.devcel.2020.06.018 Lyssiotis, 2017, Metabolic interactions in the tumor microenvironment, Trends Cell Biol, 27, 863, 10.1016/j.tcb.2017.06.003 Liang, 2013, Estrogen and cancer, Annu. Rev. Physiol., 75, 225, 10.1146/annurev-physiol-030212-183708 Jameera, 2017, Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review, Bioorg. Chem, 71, 257, 10.1016/j.bioorg.2017.02.011